<乌鸦传媒>Forego Radiotherapy for Women With Low-Risk Luminal A Breast Cancer? Study shows 5-year local recurrence rate of 2.3% with lumpectomy and endocrine therapy alone Jun 07, 2022
<乌鸦传媒>Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancer DESTINY-Breast04 extends agent's benefits to historically tough-to-treat disease Jun 05, 2022
<乌鸦传媒>Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancer But benefit seems to be predominantly in patients with PI3K/AKT/PTEN pathway alterations Jun 05, 2022
<乌鸦传媒>Sacituzumab Govitecan Boosts PFS in Late-Line HR+/HER2- Metastatic Breast Cancer "This may be something that really changes the lives of these women for the better," expert says Jun 05, 2022
<乌鸦传媒>Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer More than half of everolimus-treated patients permanently discontinued treatment Jun 02, 2022
<乌鸦传媒>Prone Beats Supine Positioning for WBRT in Women With Large Breasts Prone position led to lower rates of moist desquamation May 27, 2022
<乌鸦传媒>Black Patients Often Never Given a Chance to Join Breast Cancer Trials But survey finds several actionable findings that could boost enrollment May 26, 2022
<乌鸦传媒>Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancer Prescribing rate is half that of women with no breast cancer history May 13, 2022
<乌鸦传媒>Screening, Early Detection Remain Keys to Lower Cancer Mortality Presidential panel sets course to remove barriers, increase services, and improve uptake May 05, 2022
<乌鸦传媒>Young Cancer Survivors Face Higher Risk of Death From Second Malignancies Study finds 25% higher risk of secondary cancers versus general public, 84% higher risk of death May 04, 2022
<乌鸦传媒>Menstrual Cycles Point to Link Between Sex Hormones and Long QT Research suggests new tools for risk stratification and therapy May 01, 2022
<乌鸦传媒>DCIS Recurrence Often Represents a New Primary Breast Cancer Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
<乌鸦传媒>RT Prior to Mastectomy, Reconstruction Shows Promise U.K. study demonstrates low complication rates and good aesthetic results Apr 08, 2022
<乌鸦传媒>Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
<乌鸦传媒>New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomy Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
<乌鸦传媒>3D Mammograms Deliver Fewer False-Positive Findings However, half of women will have a false positive with annual screening with DBT Mar 25, 2022
<乌鸦传媒>FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancer Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
<乌鸦传媒>Fluorescence-Guided Lumpectomy Shows Promise Imaging system reduced the need for re-excision in one-fifth of patients Mar 11, 2022
<乌鸦传媒>Androgen Receptor Agonist Active in Resistant ER+ Breast Cancer Also: Combination targets uncommon form of advanced HER2-mutant disease Mar 09, 2022
<乌鸦传媒>More Options for Precision Medicine in Metastatic Triple-Negative Breast Cancer Moving beyond chemotherapy to immunotherapy, PARP inhibitors, ADCs, combinations Mar 08, 2022
<乌鸦传媒>Chipping Away at the Dogma of Axillary Dissection in Breast Cancer Ongoing trials could help some women avoid even less-invasive sentinel lymph node biopsy Mar 07, 2022
<乌鸦传媒>Clinical Picture Brightens for HER2+ Breast Cancer With Brain Metastases New therapies breach blood-brain barrier to improve response, survival Mar 07, 2022
<乌鸦传媒>Honing the Indications for Adjuvant CDK4/6 Inhibition in Breast Cancer Defining high risk, considering role of Ki-67, BRCA mutations Mar 05, 2022
<乌鸦传媒>Older Patients With Low-Risk DCIS May Not Benefit From Surgery, Radiation Low rate of invasive recurrence, benefits of surgery and RT limited to patients under 70 Jan 05, 2022
<乌鸦传媒>Trastuzumab ADC Active in HER2-Low, HER2-Undetected Breast Cancer No clear explanation for responses to HER2-targeted drug in HER2-negative tumors Dec 12, 2021
<乌鸦传媒>Neratinib-Based Combo Shows Efficacy in HR+, HER2-Mutant Metastatic Breast Cancer Objective response rate of 42% in patients previously treated with CDK4/6 inhibitors Dec 12, 2021
<乌鸦传媒>Benefits of Ovarian Suppression Persist in Premenopausal Breast Cancer Aromatase inhibitor-ovarian suppression tops tamoxifen strategies at 12-13 years Dec 09, 2021
<乌鸦传媒>Highly Mutated Breast Cancer Responds to Immunotherapy Nivolumab-ipilimumab combination associated with durable response in small study Dec 09, 2021
<乌鸦传媒>Ribociclib's OS Benefit in Breast Cancer Seen Regardless of Metastatic Site Second analysis shows OS benefit consistent across some intrinsic subtypes as well Dec 09, 2021
<乌鸦传媒>No Benefit With Metformin in Early Breast Cancer, Regardless of ER/PR Status However, there could be improved outcomes in HER2-positive patients Dec 08, 2021
<乌鸦传媒>Small PFS Boost With HDAC Inhibitor for Advanced HR-Positive Breast Cancer Chinese study contradicts U.S. trial that showed no benefit with entinostat add-on Dec 08, 2021
<乌鸦传媒>Black Women Most at Risk for Post-Surgical Lymphedema Black women seemed to have triple the odds of swelling after axillary lymph node dissection Dec 08, 2021
<乌鸦传媒>TROP2-Directed ADC Promising in Advanced Triple-Negative Breast Cancer Datopotamab deruxtecan turns in solid phase I results Dec 08, 2021
<乌鸦传媒>Novel Endocrine Drug Slows Previously Treated HR-Positive Breast Cancer Elacestrant led to significant improvement in all patients, ESR1-mutant subgroup Dec 07, 2021
<乌鸦传媒>Artificial Intelligence Tool Gets High Marks in Reading Mammograms Breast cancer screening results show AI's mettle in real-world dataset Dec 02, 2021
<乌鸦传媒>Low-Quality Mammography Leading to More Deaths in Black Women, Says Expert In cities like Chicago, Black women face higher breast cancer mortality versus white women Oct 26, 2021
<乌鸦传媒>No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer Women with medially or centrally located tumors may be candidates, however, says researcher Oct 26, 2021
<乌鸦传媒>More Evidence for Safety of Accelerated Radiation in Early Breast Cancer Studies show low toxicity with few recurrences Oct 25, 2021
<乌鸦传媒>Analysis Confirms Benefits of CDK4/6 Inhibition in Early Breast Cancer Reduced risk of recurrence, distant relapse with adjuvant abemaciclib Oct 20, 2021
<乌鸦传媒>'Modest' Link Between Infertility and Postmenopausal Breast Cancer Study finds increased risk for younger women, those with primary infertility Oct 19, 2021
